AI Science Tracker

Virchow: pan-cancer detection using a pathology foundation model

Paige; Microsoft Research; Memorial Sloan Kettering Cancer Center · 22 Jul 2024 · medicine

Discovery

Virchow: pan-cancer detection using a pathology foundation model

Using Virchow pathology-model embeddings, a pan-cancer detector achieved a specimen-level AUC of 0.95 across nine common and seven rare cancer types. The held-out evaluation included 6,142 specimens from Memorial Sloan Kettering Cancer Center and external institutions. Separate comparisons approached the performance of tissue-specific clinical products and exceeded them on some rare variants. This is diagnostic validation on existing specimens, not evidence that the Virchow detector itself was deployed or improved patient outcomes.

Technology: Virchow (vision transformer foundation model for pathology)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: A pan-cancer detector built on Virchow embeddings was evaluated on a held-out set of 6,142 specimens from Memorial Sloan Kettering and external institutions, and compared with tissue-specific clinical products.
  • Still unknown: The abstract does not establish deployment or patient-outcome benefit; no explicit limitations are stated.
  • AI role: The Virchow pathology foundation model provided embeddings for the pan-cancer detector.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41591-024-03141-0&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 898 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.